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Purpose: This report describes our experience with endovascular stented graft repair of 
abdominal aortic aneurysms and other arterial lesions. 
Methods: Between September 1990 and April 1994, 57 patients were treated with 
endovascular stented grafts (50 with abdominal aortic aneurysms or iliac aneurysms; five 
with traumatic arteriovenous fi tulas; one with an infected femoral false aneurysm; and 
one with a false aneurysm of the proximal right common carotid artery). The devices 
consist of either a Dacron or an autogenous vein graft sutured to a balloon-expandable 
stent. The stented grafts are placed through remote arteriotomies, advanced under 
fluoroscopic guidance to their predetermined sites, and secured into position. 
Results: Forty of the 50 endovascular stented graft procedures used to treat abdominal 
aortic aneurysms or iliac aneurysms were considered successful, even though some 
secondary treatment was required in six patients (two open operations; four secondary 
endovas~mlar p ocedures). The 10 failures include four early procedural deaths, one late 
procedural death, and five leaks. All five arteriovenous fi tulas and the two false aneurysms 
were successfully treated with endovascular stented grafts. 
Conclusions: Although our experience with endovascular stented grafts has been promis- 
ing, remaining problems require resolution, and further follow-up is needed. However, 
the potential advantages of these endovascular g afts warrant heir continued evaluation. 
(J VASC SURG 1995;21:549-57.) 
The diagnosis of abdominal aortic aneurysm 
(AAA) has been established with increasing fre- 
quency during the past 2 decades. 1 Although AAA 
may cause distal embolization, rupture remains the 
most common and deadly complication. For nearly 
40 years, elective replacement with a synthetic graft 
has proven to be the most appropriate method to 
prevent AAA rupture, and it has been associated 
with a postoperative mortality rate of less than 5% 
at most medical centers. 2 Nonfatal complica- 
tions occur with some regularity, irrespective of 
the setting in which the operation is performed. 
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Increasingly, vascular surgeons are encountering 
older patients with severe comorbid medical 
conditions, which can increase operative morbidity 
rates and may significantly elevate mortality rates 
for aortic surgery? Alternative forms of treat- 
ment, such as axillofemoral bypass in conjunction 
with induced AAA thrombosis, have generally been 
abandoned despite preliminary reports of their 
Success  .4 
In 1976, we began to develop a plan for the 
endovascular g aft treatment of AAAs and performed 
studies of experimental aneurysm treatment with 
such grafts in dogs. 5,6 The first several clinical cases 
were described in 1991. 6 This report describes the 
status of this procedure, which has now been 
performed on 50 patients with AAAs or aortoiliac 
aneurysms. In addition, it will describe seven addi- 
tional patients who had endovascular g aft treatment 
of other arterial lesions: five posttraumatic arteriove- 
nous fistulas (AVFs), one infected femoral false 
aneurysm, and one false aneurysm of the right 
common carotid artery. 
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Fig. 1. These elements comprise ndovascular stented graft device. These include (from top): 
valvuloplasty balloon catheter with tapered tip; guide wire; Teflon sheath with hemostatic valve 
at end closest o operator; Palmaz-type stent; and crimped Dacron graft. 
/ 
/ 
/ 
Fig. 2. Illustration of assembled endovascular stented graft device (bottom). Also depicted are 
methods for affixing graft to stent and wrapping raft to give it low profile (top) so that it can 
be inserted within sheath (middle). 
MATERIAL  AND METHODS 
Stented graft device 
We use a 45 cm long, 18F (inner diameter), 
Teflon sheath that contains the balloon catheter and 
a hemostatic valve at the operator end (Fig. 1). The 
balloon catheter consists of a 9F polyethylene shaft 
and one nylon balloon that is 3.5 cm in length and 
either 30, 25, or 16 mm in inflated diameter. 
Mounted on the deflated balloon is a balloon- 
expandable stent. A thin-walled, crimped, knitted 
Dacron graft is sutured to the stent overlapping one 
half of its length (Fig. 2). 
The stent we are currently using is a modification 
of the Palmaz stent, which was redesigned so that 
it could reach 30 mm in diameter when deployed. 
The length of  the stent when it is not deployed is 
3.5 cm, and the inifal diameter is 4.6 mm. The 
balloon-expandable st nt is constructed in one piece 
to prevent motion between the parts. The material 
used in these stents is the same as that used in the 
Palmaz stent (Johnson & Johnson, Warren, N.J.) 
namely stainless teel, 316L. These stents are not 
commercially available. They are manufactured for 
us by Barone Industries (Buenos Aires, Argentina). 
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The Dacron graft is a thin-walled (0.2 mm wall 
thickness), weft-knitted tube constructed from poly- 
ester fibers (E.I. duPont de Nemours and Com- 
pany). The compliant ends of the graft can be 
expanded up to 45% of their initial diameter. This 
compliance is obtained by knitting the graft with 
a wider net. Extra yarns are knitted into the graft 
to prevent unraveling. The diameters of the grafts 
are 18 and 20 mm when tubular grafts are used and 
18 and 8 mm when tapered grafts are used for 
aortoiliac placement. These grafts are not commer- 
cially available and are manufactured for us by 
Barone Industries. We currently use balloons that 
are constructed of a nylon material that has some 
degree of compliance. This compliance has allowed 
us to use only two balloon sizes (25 and 30 mm 
in diameter). For aortoiliac grafting two indepen- 
dent balloons (25 and 12 mm in diameter) are used. 
In cases in which AVFs or false aneurysms were 
treated, an expandable Dacron graft was used to 
cover most of a single stent. However, in two cases 
the stent was covered with autogenous vein because 
of the possibility of infection. 
Procedure 
Details of the procedure for treatment of AAAs 
have been previously reported. 6 After administration 
of local or epidural anesthetic, the patient is prepared 
and draped as for a standard AAA resection. A small 
incision is made over the common femoral artery that 
is distal to the straightest, widest iliac artery. A 
soft-tipped guide wire is advanced into the aorta up 
to the level of the diaphragm. A pigtail diagnostic 
catheter is advanced over the wire and placed inside 
the lumen of the aorta with the tip located proximal 
to the renal arteries. An injection of 30 cc of contrast 
media is made. The pigtail catheter has radiopaque 
marks on its surface very 2 cm to facilitate length and 
diameter measurements. By use of previously ob- 
tained arteriographic and computed tomography 
(CT) scan images, as well as the operative angiogram, 
target areas for stent deployment are defined. These 
include the proximal neck of the aneurysm and distal 
cuff (if it exists) or the common lilac artery (in the 
absence of a distal cuff). Under fluoroscopic guid- 
ance, the preloaded sheath, which contains the 
stented graft mounted on the balloon, is placed inside 
the lumen of the aneurysm. Once in place, the sheath 
is retracted and the cranial balloon is inflated with a 
diluted solution of ionic contrast media and saline 
solution. The balloon is kept inflated for 1 minute 
and then deflated. Before proceeding with balloon 
inflation, the mean blood pressure is lowered to 70 
mm Hg with use of a nitroglycerin drip and 
maintained atthat level during balloon inflation. The 
size of the balloon to be used is determined before the 
procedure and is based on the diameter of the neck of 
the aneurysm as measured on the previous angiogram 
and CT scan. After securing the proximal stent, the 
second or distal stent is placed separately to seal the 
distal end of the graft by friction. In four cascs a 
"kissing balloon" technique was used to deploy the 
distal stent completely without injuring the proximal 
common iliac arteries. Complction arteriography is 
performed. In those cases in wlhich an aortoiliac graft 
was placed, the final step involved the placement of a 
detachable balloon or closed, covered stent o occlude 
the contralateral common lilac artery and the perfor- 
mance of a femorofemoral bypass (Fig. 3). 
Two common femoral artery aneurysms were 
corrected surgically at the time of the procedure, and 
four common iliac artery temporary conduits were 
constructed with 10 mm tubular Dacron grafts to 
permit access to the aorta in the presence of very 
tortuous, stenotic iliac arteries. When a complex 
procedure was anticipated, the blood lost from the 
field was collected by a cell saver and retransfused 
after filtration. Blood loss occurred when sheaths of 
different diameters had to be changed and when 
additional procedures (such as implanting a covered 
stent) were necessary. 
When an aortoaortic procedure was performed in 
a small aneurysm with nontortuous, wide lumen iliac 
arteries, the procedure lasted 20 to 45 minutes. When 
an aortoiliac graft plus a femorofemoral bypass and 
occlusion of the conttalateral iliac artery were needed, 
the time spent in the operating room exceeded 3
hours. 
The procedures performed are summarized in 
Table I. 
Patients 
Fifty patients (45 men; 5 women) with abdomi- 
nal aortic aneurysms with or without lilac aneurysms 
or with an isolated iliac aneurysm (Table I) were 
treated between September 1990 and April 1994. 
The average age was 73 years (range 57 to 87). Five 
patients were admitted with pain probably related to 
their aneurysm, but none of the aneurysms had 
ruptured; one patient was admitted on an emergency 
basis for a rapidly growing aortic dilation caused by 
an inffarenal aortic dissection; and two were admit- 
ted with the diagnosis of "blue toe" syndrome, with 
the source of the thrombus being an AAA. In all but 
three patients, the size of the aneurysm at the time of 
treatment was more than 5 cm in diameter. Two 
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Fig. 3. Method for treating aortic and left common iliac artery aneurysm, a shows tented graft 
extending from proximal neck ofaortic aneurysm to normal right common lilac artery, b shows 
left common iliac artery occluded with detachable balloons, c shows femorofemoral bypass in 
place. Inset shows alternate approach with interruption ofproximal left common femoral artery. 
This approach is suitable when left hypogastric artery is occluded. 
Table I. Procedures performed in the 
patients with aortic or iliac aneurysms 
No. of 
Procedure patients 
Aortoaortic graft with one stent (proximal) 8 
Aortoaortic graft with 2 stents (both ends) 28 
Aortoiliac graft and femorofemoral bypass 15 + 
Ilioiliac graft 21- 
*One secondary procedure was performed after a late failure of an 
aortoaortic graft. 
Hn  one patient, simultaneous aortoaortic and ilioiliac grafts were 
used to treat an AAA and a separate common lilac artery aneurysm. 
The second patient had an isolated common lilac aneurysm. 
Table II. Associated pathologic conditions 
No. of 
Condition patients 
Severe, chronic heart disease 
Acute myocardial infarction 
Severe pulmonary insufficiency 
Renal insufficiency 
Acute hemorrhagic cerebral infarction 
Two previous strokes 
Hostile abdomen 
Cirrhosis, ascites, gastrointestinal bleeding 
Mild pulmonary insufficiency 
25 
1 
20* 
4? 
1 
1 
1 
1 
12 
*Three patients were dependent onoxygen. 
~One patient underwent dialysis. 
patients with small aneurysms causing microembo- 
lization were included in this therapeutic group. The 
third parent with an aneurysm of less than 5 cm had 
bilateral carotid endarterectomies and coronary ar- 
tery bypass performed the same year and decided to 
have his 4.5 cm AAA treated by the endoluminal 
method. The aneurysms ranged in size from 3.8 cm 
to 12 cm. All patients had at least one associated 
morbid condition (Table II). Twenty-five patients 
were in the high-risk group. Of these, the conditions 
of 17 patients were considered inoperable by at least 
two other vascular surgeons, and eight were consid- 
ered to be treatable with standard surgical proce- 
dures. These patients opted to have their AAA treated 
by an endovascular g aft. The criteria for inclusion in 
the high-risk group included age, ejection fraction of 
less than 30%, forced expiratory volume in 1 second 
of less than 800 cc, renal insufficiency, and multiple 
previous abdominal operations. In addition, the 
patient must have been examined by two indepen- 
dent vascular surgeons who believed that the risk of 
standard surgery was prohibitive. 
Five other patients had traumatic AVFs, one had 
an infected femoral false aneurysm, and one had a 
false aneurysm of the proximal right common carotid 
artery. These seven patients were treated with an 
endovascular stented graft repair. 
Written informed consent for this new procedure 
was obtained from each of the 57 patients, as well as 
from a close relative of the patient. 
RESULTS 
Forty of the 50 procedures (80%) for AAA or 
aortoiliac exclusion were considered successful, al- 
though four of the patients required placement of a 
second covered stent to repair an initial leak. The 
definition of a successful procedure included the 
complete xclusion of the aneurysm with restoration 
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of normal blood flow. In these 40 patients, the 
stented graft was in contact with normal aortic wall 
proximally and distally or iliac wall distally, and all 
flow was observed to traverse the graft without 
leakage. When the stented graft was deployed in clot, 
leakage usually occurred and was considered a failure 
of the procedure. Patients with successful procedures 
recovered very rapidly, had breakfast the next morn- 
ing, walked within 24 to 48 hours after the proce- 
dure, and were usually discharged from the hospital 
within 3 or 4 days. 
Failures (deaths and complications)' 
Ten of the 50 AAA procedures (20%) were 
considered to be failures, defined as procedural death 
or imperfect placement of the stented graft or leakage 
of blood into the aneurysmal sac. This was usually 
determined by arteriography or contrast CT scan- 
ning. Of these 10 patients with AAA who had failure 
of their endovascular graft procedure, four in the 
high-risk group died, and the graft in one patient was 
salvaged after standard operative aneurysm repair. 
Details o f t  he  five failures are as follows: incomplete 
deployment of the proximal stent resulting in migra- 
tion of the graft occurred in one patient with liver 
cirrhosis, ascites, and gastrointestinal bleeding. This 
patient was treated with a standard AAA resection. 
The patient survived the operation but died the next 
day as a consequence of abnormal bleeding. One 
patient died suddenly 2 days after the procedure. 
Postmortem examination disclosed intestinal isch- 
emia and renal infarcts, probably related to embo- 
lization during the procedure. Two patients had 
massive microembolization after difficult cndovascu- 
lar procedures in large, tortuous ancurysms and died 
after development of multiple organ failure. In the 
fifth case there was misplacement of the proximal 
stent. This was eventually treated by a standard 
surgical procedure. The patient survived and did well. 
There were three other cases of proximal leak. In 
one, the size of the aneurysm decreased in spite of a 
minimal leak. Contrast CT performed a few weeks 
later showed that the leak sealed. The patient died of 
an unrelated cause 6 months after the procedure. The 
second patient with a large proximal eak died of a 
rupture of his aneurysm 2 months after his endovas- 
cular procedure, and the third patient with a large 
proximal leak died of congestive heart failure 7 
months after his endovascular p ocedure. 
There were two other cases with distal eaks. One 
leak lasted for 3 weeks and then could not be 
identified. In the second patient a minimal distal eak 
persisted until he died of pulmonary and cardiac 
Table III. Other complications 
No. of 
Complications patients 
Groin hematoma 
Stent across renal ostia \ 
Injury to the external i iac artery treated by 
suture repair 
Minimal distal microembolization treated by 
intraarterial injection of prostaglandin 
insufficiency 8 months after the endovascular pro- 
cedure. 
Other complications 
In addition to the complications already de- 
scribed, there were several other untoward events 
(Table III). In six of the 50 aortic procedures, the 
proximal uncovered portion of the stent was placed 
across the renal ostia. However, the graft attached to 
the stent was placed istal to the renal arteries. None 
of these patients had development of renal insuffi- 
ciency. ~ Color-flow duplex scanning of renal artery 
flow has remained normal. Balloon dilation of the 
iliac arteries was performed in three cases before 
inserting the stented graft device. In one case, surgical 
repair of a ruptured lilac artery was required. 
Late results 
All patients have been monitored by clinical 
examination, color-flow duplex studies at least every 
6 months, and CT scanning at least once a year. 
Angiograms were performed in selected patients, as 
well as in those in whom the color-flow duplex or CT 
scanning suggested a leak, dilation, or any change 
from the study performed immediately after the 
procedure. The mean follow-up period has been 17 
months, with a range of 1 to 43 months. We are 
currently in the process of reviewing the CT scans 
obtained on all our patients, but it is difficult to 
obtain a measurement of the diameter of the aneu- 
rysm at precisely the same level as that obtained on 
the preprocedure study. However, it appears that in 
successful cases, if the lumen of the aneurysm islarge, 
10% to 20% reduction in the aneurysm diameter is 
evident. 
In addition to the 10 AAA patients whose 
procedures were considered failures, one patient had 
development of a distal aortic dilation 18 months 
after the initial procedure. The distal stent was placed 
too far proximal to the aortic bifurcation and was in 
contact with mural thrombus instead of undilated 
aortic wall. This was corrected at open operation by 
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adding a short segment of graft and performing a
surgical anastomosis between the old graft and the 
aortic bifurcation. The patient had an uneventful 
recovery. Three patients who had been treated with 
a device having only a proximal stent had devel- 
opment of distal reflux with shortening of the graft 
at 8, 18, and 24 months after the procedure. At 
the time of this report, two of these patients have 
been successfully treated by additional endovascular 
procedures in which a covered stent was inserted 
at the distal end of the original graft. One patient 
died 13 months after the procedure of carcinoma 
of the colon and another died of heart failure and 
respiratory insufficiency 8 months after the initial 
procedure. 
Thus of the 50 patients with AAAs or aortoiliac 
aneurysms treated by the endovascular procedure, 
there have been four early procedural deaths (8% 
mortality rate), one late procedural death, and four 
unrelated eaths. Although some secondary treat- 
ment has been required in six of the remaining 41 
patients (two open operations; four secondary endo- 
vascular procedures), the ultimate outcome has been 
satisfactory for the 1 to 43 months (mean 17 months) 
of follow-up in these patients. 
Arteriovenous fistulas and false aneurysms 
Five patients with AVFs were treated with 
endovascular stented grafts. The first, with a right 
subclavian AVF that developed after a gunshot 
wound sustained 2 years previously, had develop- 
ment of congestive heart failure as a consequence of
his fistula. A stented graft was inserted with the 
patient under local anesthesia via the brachial artery 
to close the abnormal communication. The fistula 
was eliminated, and the patient has done well for the 
subsequent 30 months. The second patient had a 
common iliac-inferior vcna cava fistula after a vascular 
injury sustained at laparoscopic surgery. A stented 
graft was inserted from the ipsilateral common 
femoral artery. The fistula was eliminated, and the 
patient remains symptom free after 17 months. A 
third patient with a left subclavian AVF was success- 
fully treated by the same method and remains well 
after 8 months. The fourth patient with an AVF 
sustained a gunshot wound several months before 
admission and had undergone four surgical attempts 
to treat an aortocaval fistula. The last Open operation 
had been unsuccessful and ended with cardiac arrest 
after exsanguination. The patient was transferred to 
our hospital and was treated by placement of an 
endovascular stented graft. This was placed via an 
open femoral arteriotomy performed with the patient 
under local anesthesia. The fistula was eliminated, 
and the patient was discharged the following day. He 
has remained well for 6 months. The fifth patient was 
a young woman who sustained a gunshot wound to 
her right thigh resulting in an AVF between the 
superficial femoral artery and vein. A covered stent 
was inserted percutaneously viathe common femoral 
artery. The AVF was eliminated, and the patient has 
remained well for 4 months. 
Another patient with renal insufficiency and 
unstable angina was admitted with an infected false 
aneurysm of the common femoral artery caused by a 
coronary stenting procedure performed 10 days 
previously. A Palmaz stent covered with autologous 
vein was deployed through the superficial femoral 
artery. The false aneurysm was eliminated, and the 
remaining abscess cavity was drained and debrided. 
The patient remains well 2 months later. A 20-year- 
old man with acquired immune deficiency syndrome 
had a gunshot wound of the chest. He was admitted 
to our hospital with a large false aneurysm of the right 
common carotid artery near its origin from the 
innominate artery. A Palmaz stent covered with an 
autologous saphenous vein graft was deployed via a 
right common femoral open arteriotomy to close the 
carotid artery defect. The false aneurysm was elimi- 
nated, and the patient remains well 3 months 
later. 
DISCUSSION 
Fifty-two endovascular stented graft procedures 
were used to treat aortic or aortoiliac aneurysms in 50 
patients, and seven were used for other applications 
(AVFs and false aneurysms). Based on our prelimi- 
nary data, we conclude that the procedure is feasible, 
and when successfully applied it has the added 
attractions of simplicity and less invasiveness. 
In this generally favorable arly experience, we 
have encountered several problems that limit the 
success and general applicability of these endovascu- 
lar stented graft procedures. First, measurements of 
diameter and length of the involved arteries and the 
lesions are crucial. After great effort, we learned how 
to obtain reasonably reliable data by use of enhanced 
CT scanning, biplaner arteriography, and three- 
dimensional reconstruction with magnetic resonance 
or CT scanning. Intraluminal measurements and 
geometric alculations have also been helpful. Cog- 
nizance of the fact that elongation occurs as dilation 
of the aorta develops and that elongation occurs in 
different planes facilitated the more accurate stima- 
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tion of graft length required to treat the aneurysm 
adequately. 
Second, several difficulties involved access prob- 
lems. Small-caliber, stenotic, and tortuous iliac arter- 
ies were responsible for these difficulties. The rigid 
stent and the large diameter of the sheath needed for 
the implantation were limitations. We were able to 
overcome some of these problems by modifying the 
device and reducing the diameter of the sheath. With 
an extra stiff guide wire, the "pull down" maneuver 
and occasional implantation of a temporary graft 
sutured to the common iliac artery via a retroperito- 
neal approach were also helpful in overcoming some 
of these problems. The "pull down" maneuver 
consists of dissecting the common femoral and 
external ilac arteries and pulling these inferiorly to 
straighten the tortuosity. 
We studied the morphologic changes in aneu- 
rysms and have found that, in the initial stage, most 
AAAs have proximal necks and distal cuffs greater 
than 2 cm. In the later stages, the distal cuff becomes 
shorter and tends to disappear, the proximal neck also 
becomes horter and elongation takes place, which 
creates tortuosity. 
Thus a third problem is absence of a distal aortic 
cuff, which does not exist in most large aneurysms. 
This requires use of a bifurcated graft 7 or an aortoiliac 
graft supplemented by placement of an occlusion 
device in the opposite common iliac artery and 
construction of a femorofemoral bypass (Fig. 3). 
A fourth problem was stent migration, which 
occurred in one of our patients. This was probably 
due to incomplete stent deployment within the 
aneurysm neck. This problem may be obviated by use 
of intraluminal ultrasonography to control stent 
deployment. 
Finally, microembolization appears to be the 
most important and as yet unresolved problem with 
endovascular graft treatment of aortic aneurysms. 
Microembolization occurred four times in our expe- 
rience, and in three, death of the patient resulted. The 
two cases that had massive microembolization also 
had technically difficult procedures performed in 
patients with large aneurysms. In one case, visceral 
embolization and ischemia were present at postmor- 
tem examination. It appears that large, tortuous 
aneurysms with a substantial amount of intraluminal 
thrombus pose an increased potential for emboli- 
zation. 
The use of stented grafts to treat arterial trauma 
appears to be one of the most important uses for 
this method, because it transforms a complicated 
and potentially dangerous procedure into a simple, 
safe one. 8'9 However, long-term follow-up will be 
required to determine the durable patency of these 
stented grafts, particularly in medium-sized arteries. 
In conclusion, our experience to date with endo- 
vascular stented grafts has been encouraging but has 
been associated with a number of problems. It is 
obvious that much work remains to be done to solve 
these problems and to develop ,devices that will be 
suitable for all cases. Moreover, it is imperative that 
the functional adequacy of these stented graft devices 
be evaluated by appropriate mid-term and long-term 
follow-up studies. Nevertheless, the potential advan- 
tages of these endovascular grafts justify their con- 
tinued use and careful evaluation. 
At the time of the last revision, three more late 
failures were identified. These late failures consisted 
of two cases of distal neck dilation with incomplete 
sealing of the graft, which resulted in leakage of blood 
into the aneurysmal cavity, and one case of proximal 
neck dilation, but in this case with no leakage into the 
aneurysmal cavity. 
REFERENCES 
1. Melton LJ, Bickerstaff LK, Hollicr LH, ct al. Changing 
incidence of abdominal aortic aneurysms: a population-based 
study. Am J Epidemiol 1984;120:379-86. 
2. Brown OW, HoUier LH, Pairolero PC, Kazmier FJ, McCready 
RA. Abdominal aortic aneurysm and coronary artery disease: a
reassessment. Arch Surg 1981; 116:1484-8. 
3. McCombs PR, Roberts B. Acutc renal failure following 
resection of abdominal aortic ancurysm. Surg Gynecol Obstet 
1979;148:175-8. 
4. Karmody AM, Leather RP, Goldman M, Corson JD, Shah 
DM. The current position of nonrcscctivc treatment for 
abdominal aortic aneurysm. Surgery 1983;94:591-7. 
5. Laborde JC, Parodi JC, Clem MF, et al. Intraluminal bypass of 
abdominal ortic aneurysm: feasibility study. Radiology 1992; 
184:185-90. 
6. Parodi JC, Palmaz 1C, Barone HD. Transfemoral intraluminal 
graft implantation for abdominal aortic aneurysms. Ann Vase 
Surg 1991;5:491-9. 
7. Chuter T. Bifurcated endovascular graft insertion for abdomi- 
nal aortic aneurysms. In: Greenhalgh RM, ed. Vascular and 
endovascular surgical techniques: an atlas. 3rd ed. London: WB 
Saunders, 1994:92-9. 
8. Parodi JC, Barone HD, Schonholz C. Transfemoral endovas- 
cular treatment of aortoiliac aneurysms and arteriovenous 
fistulas with stented Dacron grafts. In: Veith H, ed. Current 
critical problems in vascular surgery. St. Louis: Quality Medical 
Publishing, 1993;5:264. 
9. Marin ML, Veith FJ, Panetta TF, et al. Transluminally placed 
endovascular stented graft repair for arterial trauma. J VASC 
SURG 1994;20:466-73. 
Submitted July 22, 1994; accepted Nov. 11, 1994. 
JOURNAL OF VASCULAR SURGERY 
556 Parodi April 1995 
DISCUSSION 
Dr. Timothy A. M. Chuter (Rochester, N.Y.). 
Leaving aside the case of trauma, this is a most important 
study on endovascular neurysm repair for four reasons. It 
is the largest series, personal or otherwise. The follow-up 
covers the longest period. 
The patients were not selected to meet the narrow 
inclusion criteria of a formal clinical study, but they 
exhibited awide variety of arterial anatomy and comorbid 
disease. The same insights that enabled Dr. Parodi to make 
endovascular repair a reality are reflected in his analysis of 
the resuks. An 80% success rate is remarkable, given the 
challenging circumstances present in many of these cases. 
Perhaps the most troubling of the reported complications 
and failures is microembolization, because it is not 
amenable to surgical correction and can be deadly. Large 
aneurysms and extensive manipulation were identified as 
contributing factors. How does this influence your patient 
selection? I ask this, not having seen embolism, but having 
excluded apatient from endovascular repair on the basis of 
a CT scan result that showed two lumens through the 
thrombus in his distal aneurysm. 
Regarding the importance of preoperative measure- 
ment, could you describe your current protocol and 
comment on any disparities een when multiple techniques 
were used? 
Three anatomic patterns were described: small aneu- 
rysms with a distal neck, larger aneurysms with relatively 
symmetric iliac arteries, and large aneurysms with marked 
twisting and angulation of the aorta and iliac arteries. I
agree that the disappearance of the distal neck and 
increasing tortuosity of the aorta and iliac arteries that 
accompany aneurysm enlargement clearly have important 
implications on the technique of endovascular repair. 
Having treated 18 aneurysms with bifurcated grafts, I have 
yet to find any patients uitable for straight graft repair 
(group 1), and I do not regard iliac tortuosity as a 
contraindication to bifurcated graft repair. Do you have 
any data on the range of aneurysm size typical of each 
group? 
I find little evidence to support he contention that the 
Palmaz stent represents the ideal proximal attachment 
device. The purpose of the proximal stent in an endovas- 
cular prosthesis i to prevent leakage and migration. In my 
experience, a graft secured with a self-expanding Z-stent in 
the neck of the aneurysm, does not leak and does not 
migrate. 
The same cannot be said of the Palmaz stent. 
I agree that intravascular ultrasonography may have an 
important role in assessing stent implantation and revealing 
irregularities in the graft surface. But, like you, I have very 
limited clinical experience with this imaging modality. 
Two helpful techniques are described for dealing with 
access problems, which are worth repeating. One is the 
application of traction to a partially dissected external i iac 
artery to induce straightening. I have used this twice; it 
works. Another is the insertion of a guide wire from the 
axillary artery when the aneurysm is large. Volodos has 
reported using this method since the late 1980s. 
One technical point that was less clear regarding 
possible modifications in the delivery system. Could you 
tell us whether the 18F sheath, containing the 
graft/stent/balloon assembly, was introduced irectly into 
the artery or passed through another, larger sheath? 
Dr. Juan C. Parodi. Regarding patient selection to 
prevent microembolization, we have seen three patients 
with spontaneous microembolization, and we did not have 
any troubles with them, but they had small aneurysms. I am 
not planning to exclude any patient at this point. What I am 
planning to do is just be more careful and come down from 
the brachial artery, perhaps with a small balloon catheter, 
which we are now developing. With that balloon catheter 
we can insert the wire upward. Regarding how we 
measured the aneurysm, the best way is to have spiral CT 
scanning with special software to rotate the image 360 
degrees and have 10 segments of this image, because you 
have a two-dimensional screen and a three-dimensional 
aneurysm. So by rotating the reconstructed image and 
getting the longest segment of any kind of rotation, we can 
measure the length exactly. 
Regarding the patterns we found in different stages of 
aneurysm evolution, we do not see this in all cases. 
Sometimes we have large aneurysms with no tortuosity and 
with good proximal and distal neck, but, at least in most of 
our patients after their aneurysm reaches 5.5 cm in 
diameter, it becomes tortuous. When you find small 
aneurysms of 3.5 or 4.0 cm, usually you have a good 
proximal and distal neck. Five-centimeter aneurysms start 
losing the distal neck. With aneurysms larger than 5.5 cm, 
you start having tortuosity. 
Regarding attachment devices you can use several 
malleable plastic or metallic devices. Regarding the delivery 
system, I use a one-sheath system, 16F with a nose cone at 
the end. If you use a double sheath system, you should use 
a 20F sheath. 
Dr. Michael Matin (New York, N.Y.). With regard to 
the use of different types of stents as Dr. Chuter has 
instructed, it is clear that anybody who has performed 
enough of these procedures and has seen the complexity of 
the disease will know that any stent, even in the best of 
designs, will produce some degree of leak in certain 
patients. Anybody who has seen no leaks around the stent 
and into the graft area in endoluminal grafts has not done 
enough cases. We also have had experience with this 
particular problem, which is of great concern and fre- 
quently can be fatal. Is there anything we can learn before 
operation that can predict his complication? For instance, 
are there features in CT scanning, such as the thrombus 
itself, that we can diagnose in a preoperative setting that 
would tell us which patients would be at risk for 
development of this horrible complication? 
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Dr. Parodi. We reviewed the medical literature about 
this, and we are now studying surgical cases by comparing 
the CT scan results and studying the inner surface of the 
thrombus. When you have a double lumen and an irregular 
surface inside, the patient is at high risk. Spontaneous 
embolizafion i a patient indicates to the presence of friable 
material. I think we have to work and refine this technique. 
Dr. Luis A. Queral (Baltimore, Md.). Of all the 
aneurysm cases that are referred to you, what percent do 
you submit for endovascular treatment and what percent 
do you submit for standard surgical treatment or traditional 
approach, and what criteria do you use to make this 
important decision? 
Dr. Parodi. We started with very difficult cases, and we 
were successful in the beginning. We had a very strange 
learning curve. We did not have problems in the beginning, 
but when we had some experience, we started treating all 
cases, even ones with a 1 cm proximal neck. After case 
number 20, we started to have problems. I was close to 
quitting after case 22. I had two consecutive cases with 
microembolization, and I stopped the trial for 2 weeks. 
Then we monitored a case that was very simple, and we 
started again. Now we are more careful than we were 
before. I think it is wise to do what Dr. Moore is doing, 
which is to treat simple cases with small aneurysms. But 
very often we receive patients who have an aneurysm that 
has grown 2 or 3 cm in the last month, and the patients are 
having back pain, ejection fraction of 12%, and congestive 
heart failure. We decide to go ahead and treat it because 
that patient is going to have a ruptured aneurysm and die 
anyway. So the risk is high but it is not as high as the normal 
evolution. 
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